Speaking & Events

Thrilled to be speaking at IMAPAC's Cell & Gene Therapy World Asia 2026 in Singapore, APAC's premier CGT congress now in its 10th edition. Joining 500+ attendees and 50+ speakers from across the region to share the latest on Biosceptre's BRiDGECAR™ platform.

I presented "Architecture of Control: The Molecular Design Behind BRiDGECAR™" on Wednesday 1 July at 11:00am (SGT), walking the international CGT community through the precision engineering behind our modular CAR-T technology.

This came alongside our CEO Gavin Currie's talk, "One CAR-T, Empowering Clinical Choice: The BRiDGECAR™ Platform," on Tuesday 30 June. Together, the two presentations gave the community a complete picture of BRiDGECAR™ — from the clinical flexibility it offers physicians through to the precision engineering that makes it possible — underscoring the platform's readiness for the next phase of growth as it advances through haematological and solid tumour programmes toward clinical translation.

A heartfelt thank you to our brilliant panel — Prof Shane T. Grey, Alinta Furnell, Ziduo (Cindy) Li, Sophie Octavia, and David Barda. The discussions were refreshing, grounded, and truly inspiring, masterfully guided by the world-renowned genomics expert, Prof Marc Wilkins.

This wonderful event would not have been possible without the support of my talented, creative, and amazing colleagues and friends: Nihan Tokol Turgutoglu, Zain Al Abdin, Sharona Ta, and Ezra Harvey P.

It was such an honour to share our CAR-T platform at the ISCT ANZ Regional Meeting in Sydney last Friday. A huge thank-you to the organisers for the excellent program and fantastic presenters.

Most of all, it was wonderful connecting with the cell and gene therapy community across Australia and New Zealand, sharing updates on Biosceptre's BRiDGECAR™ universal CAR-T platform and learning from the broader field.